These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 30707730

  • 1. Bacterial causes of otitis media with spontaneous perforation of the tympanic membrane in the era of 13 valent pneumococcal conjugate vaccine.
    Levy C, Varon E, Ouldali N, Wollner A, Thollot F, Corrard F, Werner A, Béchet S, Bonacorsi S, Cohen R.
    PLoS One; 2019; 14(2):e0211712. PubMed ID: 30707730
    [Abstract] [Full Text] [Related]

  • 2. Pneumococcal serotype 19A is the major cause of pediatric acute otitis media with ruptured tympanic membrane in Addis Ababa, Ethiopia, 5 years after the introduction of the ten-valent pneumococcal conjugate vaccine.
    Negash AA, Asrat D, Abebe W, Hailemariam T, Gebre M, Aseffa A, Vaneechoutte M.
    Int J Pediatr Otorhinolaryngol; 2019 Nov; 126():109638. PubMed ID: 31442868
    [Abstract] [Full Text] [Related]

  • 3. Epidemiology of Otitis Media with Spontaneous Perforation of the Tympanic Membrane in Young Children and Association with Bacterial Nasopharyngeal Carriage, Recurrences and Pneumococcal Vaccination in Catalonia, Spain - The Prospective HERMES Study.
    Cilveti R, Olmo M, Pérez-Jove J, Picazo JJ, Arimany JL, Mora E, Pérez-Porcuna TM, Aguilar I, Alonso A, Molina F, Del Amo M, Mendez C, HERMES Study Group.
    PLoS One; 2017 Nov; 12(2):e0170316. PubMed ID: 28146590
    [Abstract] [Full Text] [Related]

  • 4. Bacterial spectrum of spontaneously ruptured otitis media in the era of pneumococcal conjugate vaccination in Germany.
    van der Linden M, Imöhl M, Busse A, Rose M, Adam D.
    Eur J Pediatr; 2015 Mar; 174(3):355-64. PubMed ID: 25169065
    [Abstract] [Full Text] [Related]

  • 5. Pathogens implicated in acute otitis media failures after 7-valent pneumococcal conjugate vaccine implementation in France: distribution, serotypes, and resistance levels.
    Couloigner V, Levy C, François M, Bidet P, Hausdorff WP, Pascal T, Boucherat M, Bingen E, Mariani P, Pierrot S, Bille E, Carbonnelle E, Varon E, Cohen R.
    Pediatr Infect Dis J; 2012 Feb; 31(2):154-8. PubMed ID: 21983212
    [Abstract] [Full Text] [Related]

  • 6. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine.
    Casey JR, Adlowitz DG, Pichichero ME.
    Pediatr Infect Dis J; 2010 Apr; 29(4):304-9. PubMed ID: 19935445
    [Abstract] [Full Text] [Related]

  • 7. Etiology of Acute Otitis Media and Characterization of Pneumococcal Isolates After Introduction of 13-Valent Pneumococcal Conjugate Vaccine in Japanese Children.
    Ubukata K, Morozumi M, Sakuma M, Takata M, Mokuno E, Tajima T, Iwata S, AOM Surveillance Study Group.
    Pediatr Infect Dis J; 2018 Jun; 37(6):598-604. PubMed ID: 29474258
    [Abstract] [Full Text] [Related]

  • 8. Pneumococcal conjugate vaccines for preventing acute otitis media in children.
    de Sévaux JL, Venekamp RP, Lutje V, Hak E, Schilder AG, Sanders EA, Damoiseaux RA.
    Cochrane Database Syst Rev; 2020 Nov 24; 11(11):CD001480. PubMed ID: 33231293
    [Abstract] [Full Text] [Related]

  • 9. Non-typeable Haemophilus influenzae and Streptococcus pneumoniae as primary causes of acute otitis media in colombian children: a prospective study.
    Sierra A, Lopez P, Zapata MA, Vanegas B, Castrejon MM, Deantonio R, Hausdorff WP, Colindres RE.
    BMC Infect Dis; 2011 Jan 05; 11():4. PubMed ID: 21208431
    [Abstract] [Full Text] [Related]

  • 10. Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule.
    Wiertsema SP, Kirkham LA, Corscadden KJ, Mowe EN, Bowman JM, Jacoby P, Francis R, Vijayasekaran S, Coates HL, Riley TV, Richmond P.
    Vaccine; 2011 Jul 18; 29(32):5163-70. PubMed ID: 21621576
    [Abstract] [Full Text] [Related]

  • 11. Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: shifting pathogens in the post-pneumococcal conjugate vaccination era.
    Pumarola F, Marès J, Losada I, Minguella I, Moraga F, Tarragó D, Aguilera U, Casanovas JM, Gadea G, Trías E, Cenoz S, Sistiaga A, García-Corbeira P, Pirçon JY, Marano C, Hausdorff WP.
    Int J Pediatr Otorhinolaryngol; 2013 Aug 18; 77(8):1231-6. PubMed ID: 23746414
    [Abstract] [Full Text] [Related]

  • 12. A prospective, observational, epidemiological evaluation of the aetiology and antimicrobial susceptibility of acute otitis media in Saudi children younger than 5years of age.
    Al-Mazrou KA, Shibl AM, Kandeil W, Pirçon JY, Marano C.
    J Epidemiol Glob Health; 2014 Sep 18; 4(3):231-8. PubMed ID: 25107659
    [Abstract] [Full Text] [Related]

  • 13. Antibiotic Resistance of Potential Otopathogens Isolated From Nasopharyngeal Flora of Children With Acute Otitis Media Before, During and After Pneumococcal Conjugate Vaccines Implementation.
    Rybak A, Levy C, Bonacorsi S, Béchet S, Vié le Sage F, Elbez A, Varon E, Cohen R.
    Pediatr Infect Dis J; 2018 Mar 18; 37(3):e72-e78. PubMed ID: 29227464
    [Abstract] [Full Text] [Related]

  • 14. Epidemiology and antimicrobial susceptibility of non-typeable Haemophilus influenzae in otitis media in Taiwanese children.
    Cho YC, Chiu NC, Huang FY, Huang DT, Chang L, Huang CY, Kung YH, Lee KS, Chi H.
    J Microbiol Immunol Infect; 2019 Feb 18; 52(1):75-80. PubMed ID: 28988664
    [Abstract] [Full Text] [Related]

  • 15. Pneumococcal conjugate vaccines for preventing acute otitis media in children.
    Fortanier AC, Venekamp RP, Boonacker CW, Hak E, Schilder AG, Sanders EA, Damoiseaux RA.
    Cochrane Database Syst Rev; 2019 May 28; 5(5):CD001480. PubMed ID: 31135969
    [Abstract] [Full Text] [Related]

  • 16. Serotypes not Included in 13-Valent Pneumococcal Vaccine as Causes of Acute Otitis Media with Spontaneous Tympanic Membrane Perforation in a Geographic Area with High Vaccination Coverage.
    Marchisio P, Esposito S, Picca M, Baggi E, Terranova L, Orenti A, Biganzoli E, Principi N, Milan AOM Study Group.
    Pediatr Infect Dis J; 2017 May 28; 36(5):521-523. PubMed ID: 27997514
    [Abstract] [Full Text] [Related]

  • 17. Otorrhea bacterial profile, epidemiology before widespread use of the third-generation pneumococcal conjugate vaccine in French children, a prospective study from 2015 to 2023.
    Levy C, Varon E, Bidet P, Béchet S, Batard C, Wollner A, Thollot F, Bonacorsi S, Cohen R.
    Infect Dis Now; 2023 Sep 28; 53(6):104738. PubMed ID: 37331698
    [Abstract] [Full Text] [Related]

  • 18. General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines.
    Leach AJ, Wigger C, Beissbarth J, Woltring D, Andrews R, Chatfield MD, Smith-Vaughan H, Morris PS.
    Int J Pediatr Otorhinolaryngol; 2016 Jul 28; 86():224-32. PubMed ID: 27260611
    [Abstract] [Full Text] [Related]

  • 19. Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines: A randomised controlled trial.
    Beissbarth J, Wilson N, Arrowsmith B, Binks MJ, Oguoma VM, Lawrence K, Llewellyn A, Mulholland EK, Santosham M, Morris PS, Smith-Vaughan HC, Cheng AC, Leach AJ.
    Vaccine; 2021 Apr 15; 39(16):2264-2273. PubMed ID: 33766422
    [Abstract] [Full Text] [Related]

  • 20. Studying PCV impact on clinical presentation of otitis media helps to understand its pathogenesis.
    Ben-Shimol S, Givon-Lavi N, Leibovitz E, Greenberg D, Dagan R.
    Vaccine; 2019 Jan 03; 37(1):1-6. PubMed ID: 30497832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.